Table 1. The effects of Cuc IIa on mouse H22 liver cancer through abdominal administrationa.
| Dosage | Administration method | Animal number | Animal body weight (g) | Cancer weight (g) | Inhibition | |
|---|---|---|---|---|---|---|
| Sample | (mg kg−1 per day) | Ig × 10qd | Start/end | Start/end | X±s.d. | efficiency |
| Cuc IIa | 90 | Ig × 10qd | 10/9 | 21.1/27.6 | 1.31±0.12 | 57.05 |
| Cuc IIa | 60 | Ig × 10qd | 10/10 | 21.0/24.6 | 1.49±0.12 | 51.05 |
| Cuc IIa | 30 | Ig × 10qd | 10/10 | 20.8/25.4 | 1.95±0.12 | 36.07 |
| Control | Solvent | Ig × 10qd | 20/20 | 20.8/25.9 | 3.05±0.28 |
a
Compared with control, P<0.01. The difference is significant.